Target Name: DGKD
NCBI ID: G8527
Review Report on DGKD Target / Biomarker Content of Review Report on DGKD Target / Biomarker
DGKD
Other Name(s): Diacylglycerol kinase delta, transcript variant 2 | Diacylglycerol kinase delta (isoform 2) | KIAA0145 | Diglyceride kinase delta | DAG kinase delta | diacylglycerol kinase delta | Diacylglycerol kinase delta | DGKD_HUMAN | Diglyceride kinase | diacylglycerol kinase, delta 130kDa | Diacylglycerol kinase delta (isoform 1) | DGKD variant 2 | Diacylglycerol kinase delta, transcript variant 1 | DGKdelta | 130 kDa diacylglycerol kinase | dgkd-2 | DGKD variant 1 | diglyceride kinase delta | DGK-delta

Regulation of Insulin/IGF-1 Signaling Pathway By Diacylglycerol Kinase Delta (DGKD)

Diacylglycerol kinase delta (DGKD) is a protein that is expressed in various tissues throughout the body, including muscle, heart, and brain. It plays a role in the regulation of cellular signaling pathways, including the insulin/IGF-1 signaling pathway. DGKD has four isoforms, which are different forms of the protein that are produced by alternative splicing.

One of the primary functions of DGKD is to regulate the activity of the insulin/IGF-1 signaling pathway. This pathway is involved in the regulation of various cellular processes, including cell growth, metabolism, and inflammation. DGKD has been shown to play a key role in the regulation of muscle growth and development, as well as the regulation of heart function.

In addition to its role in insulin/IGF-1 signaling, DGKD has also been shown to play a role in the regulation of cellular stress responses. It has been shown to be involved in the regulation of cellular stress responses, including the regulation of inflammation and cellular death.

DGKD has also been shown to play a role in the regulation of cellular angiogenesis, which is the process by which new blood vessels are formed. DGKD has been shown to be involved in the regulation of angiogenesis, including the regulation of blood vessel diameter and the formation of blood vessels in the brain.

DGKD has also been shown to play a role in the regulation of cellular signaling pathways that are involved in cell cycle progression and the regulation of cellular paresis. DGKD has been shown to be involved in the regulation of the G1/S checkpoint, which is a critical step in the cell cycle that involves the recruitment of specific transcription factors to the nuclear genome.

DGKD has also been shown to play a role in the regulation of cellular signaling pathways that are involved in cell migration and the regulation of cellular adhesion. DGKD has been shown to be involved in the regulation of the podocalyxin (PDZ) receptor, which is involved in the regulation of cell migration and the regulation of cellular adhesion.

In addition to its role in cellular signaling pathways, DGKD has also been shown to play a role in the regulation of cellular responses to environmental stimuli. DGKD has been shown to be involved in the regulation of cellular responses to environmental stimuli, including the regulation of the production of stress hormones, such as cortisol and adrenaline.

DGKD has also been shown to play a role in the regulation of cellular responses to nutrients and the regulation of cellular responses to various signaling pathways that are involved in cellular metabolism. DGKD has been shown to be involved in the regulation of cellular responses to nutrients, including the regulation of glucose metabolism, and the regulation of cellular responses to various signaling pathways that are involved in cellular metabolism, including the regulation of insulin sensitivity.

DGKD has also been shown to play a role in the regulation of cellular responses to various signaling pathways that are involved in cellular inflammation. DGKD has been shown to be involved in the regulation of cellular responses to various signaling pathways that are involved in cellular inflammation, including the regulation of the production of pro-inflammatory cytokines.

In conclusion, DGKD is a protein that has various roles in the regulation of cellular signaling pathways, including the regulation of insulin/IGF-1 signaling, the regulation of cellular stress responses, the regulation of cellular angiogenesis, the regulation of cellular signaling pathways that are involved in cell cycle progression and the regulation of cellular responses to various signaling pathways that are involved in cellular metabolism. These roles make DGKD a potential drug target and a biomarker for various diseases, including diabetes, heart disease, and cancer. Further research is needed to fully understand the role of DGKD in

Protein Name: Diacylglycerol Kinase Delta

Functions: Diacylglycerol kinase that converts diacylglycerol/DAG into phosphatidic acid/phosphatidate/PA and regulates the respective levels of these two bioactive lipids (PubMed:12200442, PubMed:23949095). Thereby, acts as a central switch between the signaling pathways activated by these second messengers with different cellular targets and opposite effects in numerous biological processes (Probable). By controlling the levels of diacylglycerol, regulates for instance the PKC and EGF receptor signaling pathways and plays a crucial role during development (By similarity). May also regulate clathrin-dependent endocytosis (PubMed:17880279)

The "DGKD Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DGKD comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

DGKE | DGKG | DGKH | DGKI | DGKK | DGKQ | DGKZ | DGKZP1 | DGLUCY | DGUOK | DGUOK-AS1 | DHCR24 | DHCR7 | DHDDS | DHDDS-AS1 | DHDH | DHFR | DHFR2 | DHFRP3 | DHH | DHODH | DHPS | DHRS1 | DHRS11 | DHRS12 | DHRS13 | DHRS2 | DHRS3 | DHRS4 | DHRS4-AS1 | DHRS4L1 | DHRS4L2 | DHRS7 | DHRS7B | DHRS7C | DHRS9 | DHRSX | DHTKD1 | DHX15 | DHX16 | DHX29 | DHX30 | DHX32 | DHX33 | DHX34 | DHX35 | DHX36 | DHX37 | DHX38 | DHX40 | DHX57 | DHX58 | DHX8 | DHX9 | DIABLO | Diacylglycerol Acyltransferase (DGAT) | Diacylglycerol kinase | DIAPH1 | DIAPH2 | DIAPH3 | DIAPH3-AS1 | DICER1 | DICER1-AS1 | Dickkopf protein | DIDO1 | DiGeorge syndrome critical region gene 9 | Dimethylaniline monooxygenase [N-oxide-forming] | DIMT1 | DINOL | DIO1 | DIO2 | DIO2-AS1 | DIO3 | DIO3OS | DIP2A | DIP2A-IT1 | DIP2B | DIP2C | DIP2C-AS1 | Dipeptidase | Dipeptidyl-Peptidase | DIPK1A | DIPK1B | DIPK1C | DIPK2A | DIPK2B | DIRAS1 | DIRAS2 | DIRAS3 | DIRC1 | DIRC3 | DIRC3-AS1 | DIS3 | DIS3L | DIS3L2 | DISC1 | DISC1FP1 | DISC2 | Disintegrin and Metalloproteinase domain-containing protein (ADAM) (nospecified subtype) | DISP1